(Q34558250)

3 August 2017

1 reference

title

Radiotherapy as part of a multidisciplinary treatment strategy in early breast cancer (English)

1 reference

adaptive radiation therapy

3 August 2017

main subject

0 references

author name string

Overgaard M

series ordinal

1

1 reference

3 August 2017

publication date

1 October 2001

1 reference

European Journal of Cancer

3 August 2017

published in

1 reference

3 August 2017

volume

37 Suppl 7

1 reference

3 August 2017

page(s)

S33-43

1 reference

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Long-term follow-up of the first breast conservation trial: Guy' wide excision study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

The influence of young age on outcome in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Factors influencing the effect of age on prognosis in breast cancer: population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Treatment of early carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Cost-effectiveness of adding an electron-beam boost to tangential radiation therapy in patients with negative margins after conservative surgery for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Radiotherapy in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Overview of randomized trials in high risk breast cancer patients treated with adjuvant systemic therapy with or without postmastectomy irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Breast cancer survival advantage with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Radiotherapy for early breast cancer: was a comprehensive overview of trials needed?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

The link between local recurrence and distant metastases in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Postmastectomy radiotherapy: questions for the twenty-first century

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Cell kinetics, growth rate and the natural history of breast cancer. The Heuson Memorial Lecture.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

FECS Clinical Award lecture 1989. Factors in decision making in the treatment of breast cancer. Federation of European Cancer Societies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Adjuvant chest wall and nodal irradiation: maximize cure, minimize late cardiac toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Adjuvant irradiation after mastectomy in women with one to three positive axillary nodes: then no; now yes.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Cli

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Endocrine therapy of breast cancer. The experience of the Italian Cooperative Group for Chemohormonal Therapy of Early Breast Cancer (GROCTA)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the Nationa

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Consensus Statement on postmastectomy radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Influence of adjuvant irradiation on the development of late arm lymphedema and impaired shoulder mobility after mastectomy for carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Shoulder movement after the treatment of early stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Early and Late Normal-tissue Injury after Postmastectomy Radiotherapy Alone or Combined with Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Postmastectomy radiotherapy: toxicities and techniques to reduce them

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Radiation-induced ischemic heart disease in breast cancer--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

Cardiac and lung complication probabilities after breast cancer irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2980005-8

7 January 2021

10.1016/S0959-8049(01)80005-8

Identifiers

DOI

1 reference

3 August 2017

1 reference